PA
IMGN

Pinnacle Associates’s Immunogen Inc IMGN Stock Holding History

Pinnacle Associates’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-1,011,792
Closed -$30M – 855
2023
Q4 		$30M Sell
1,011,792
-4,364
-0.4% -$86.9K 0.5% 48
2023
Q3 		$16.1M Sell
1,016,156
-193,767
-16% -$3.22M 0.3% 97
2023
Q2 		$22.8M Sell
1,209,923
-116,556
-9% -$1.38M 0.4% 70
2023
Q1 		$5.09M Sell
1,326,479
-7,079
-0.5% -$30.2K 0.1% 204
2022
Q4 		$6.61M Sell
1,333,558
-15,405
-1% -$83.5K 0.14% 171
2022
Q3 		$6.45M Sell
1,348,963
-41,569
-3% -$219K 0.15% 167
2022
Q2 		$6.26M Sell
1,390,532
-14,136
-1% -$61.4K 0.14% 177
2022
Q1 		$6.69M Buy
1,404,668
+218,610
+18% +$1.21M 0.12% 194
2021
Q4 		$8.8M Buy
1,186,058
+324,176
+38% +$2.01M 0.15% 158
2021
Q3 		$4.89M Sell
861,882
-29,845
-3% -$172K 0.09% 222
2021
Q2 		$5.88M Buy
891,727
+13,669
+2% +$95.4K 0.11% 198
2021
Q1 		$7.11M Sell
878,058
-97,360
-10% -$795K 0.14% 171
2020
Q4 		$6.29M Sell
975,418
-65,013
-6% -$379K 0.13% 175
2020
Q3 		$3.75M Sell
1,040,431
-46,603
-4% -$188K 0.09% 211
2020
Q2 		$5M Sell
1,087,034
-10,971
-1% -$46.7K 0.12% 179
2020
Q1 		$3.74M Sell
1,098,005
-173,182
-14% -$757K 0.11% 188
2019
Q4 		$6.49M Sell
1,271,187
-86,940
-6% -$295K 0.14% 167
2019
Q3 		$3.29M Sell
1,358,127
-81,738
-6% -$217K 0.08% 243
2019
Q2 		$3.13M Sell
1,439,865
-167,731
-10% -$397K 0.07% 254
2019
Q1 		$4.36M Buy
1,607,596
+698,820
+77% +$3.03M 0.1% 216
2018
Q4 		$4.36M Sell
908,776
-33,404
-4% -$203K 0.11% 202
2018
Q3 		$8.92M Sell
942,180
-154,757
-14% -$1.49M 0.19% 146
2018
Q2 		$10.7M Sell
1,096,937
-170,570
-13% -$1.8M 0.22% 123
2018
Q1 		$13.3M Sell
1,267,507
-54,724
-4% -$541K 0.26% 102
2017
Q4 		$8.48M Sell
1,322,231
-144,448
-10% -$891K 0.16% 157
2017
Q3 		$11.2M Sell
1,466,679
-50,960
-3% -$339K 0.21% 116
2017
Q2 		$10.8M Sell
1,517,639
-72,320
-5% -$331K 0.21% 119
2017
Q1 		$6.15M Sell
1,589,959
-33,165
-2% -$96.8K 0.12% 180
2016
Q4 		$3.31M Sell
1,623,124
-116,052
-7% -$233K 0.07% 253
2016
Q3 		$4.66M Sell
1,739,176
-26,870
-2% -$78.1K 0.09% 206
2016
Q2 		$5.44M Sell
1,766,046
-64,893
-4% -$407K 0.12% 184
2016
Q1 		$15.6M Buy
1,830,939
+62,580
+4% +$529K 0.33% 85
2015
Q4 		$24M Buy
1,768,359
+545,784
+45% +$6.72M 0.5% 53
2015
Q3 		$11.7M Sell
1,222,575
-38,745
-3% -$566K 0.26% 96
2015
Q2 		$18.1M Sell
1,261,320
-10,320
-0.8% -$113K 0.34% 80
2015
Q1 		$11.4M Buy
1,271,640
+32,548
+3% +$236K 0.21% 111
2014
Q4 		$7.56M Buy
1,239,092
+3,230
+0.3% +$29.5K 0.15% 157
2014
Q3 		$13.1M Buy
1,235,862
+398,505
+48% +$4.51M 0.27% 104
2014
Q2 		$9.92M Sell
837,357
-46,290
-5% -$581K 0.19% 125
2014
Q1 		$13.2M Sell
883,647
-37,510
-4% -$591K 0.26% 98
2013
Q4 		$13.5M Sell
921,157
-19,696
-2% -$303K 0.26% 99
2013
Q3 		$16M Sell
940,853
-8,722
-0.9% -$153K 0.33% 83
2013
Q2 		$15.8M Buy
+949,575
New +$15.4M 0.35% 80

Other funds holding IMGN

IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
MG
Mather Group Chicago, Illinois $10B AUM 15.14% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Pinnacle Associates's IMGN Position: Q1 2024 in Review

Pinnacle Associates sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 1,011,792 shares — an estimated $30M sold.

Pinnacle Associates first reported a position in IMGN in Q2 2013 and held it in 43 quarters. The position peaked at $30M in Q4 2023. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.

  • Pinnacle Associates reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
  • Pinnacle Associates sold 1,011,792 Immunogen Inc shares in Q1 2024, an estimated $30M.
  • Pinnacle Associates first reported a position in Immunogen Inc in Q2 2013 and held it in 43 quarters.
  • Pinnacle Associates's Immunogen Inc position peaked at $30M in Q4 2023.
  • 3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.

Based on Pinnacle Associates's 13F filing for Q1 2024, filed 26 Apr 2024.